| CAS登录号 | 中文名 | 英文名 | 分子结构式 | 分子式 | 详情 | 供应商 |
| 3680-71-5 | 4-羟基吡咯并[2,3-d]嘧啶 | Pyrrolo[2,3-d]pyrimidin-4-ol; 7H-Pyrrolo[2,3-d]pyrimidin-4-ol | ![]() | C6H5N3O | 详情 | 供应商 |
| 7355-55-7 | 2-氨基-4-羟基吡咯并[2,3-d]嘧啶 | 2-Amino-4-hydroxypyrrolo[2,3-d]pyrimidine; 7-Deazaguanine | ![]() | C6H6N4O | 详情 | 供应商 |
| 39929-79-8 | 2,4-二羟基吡咯[2,3-d]嘧啶 | 7H-Pyrrolo[2,3-d]pyrimidine-2,4-diol; 7H-Pyrrolo[2,3-d]pyrimidine-2,4-diol(6CI); 7-Deazaxanthine | ![]() | C6H5N3O2 | 详情 | 供应商 |
| 7781-10-4 | 4-氯-7-甲基吡咯并[2,3-D]嘧啶 | 4-Chloro-7-methyl-7H-pyrrolo[2,3-d]pyrimidine | ![]() | C7H6ClN3 | 详情 | 供应商 |
| 859212-16-1 | 巴氟替尼; 巴氟替尼; 4-[[(3S)-3-二甲基氨基吡咯烷-1-基]甲基]-N-[4-甲基-3-[(4-嘧啶-5-基嘧啶-2-基)氨基]苯基]-3-(三氟甲基)苯甲酰胺; N-[3-([4,5'-联嘧啶]-2-基氨基)-4-甲基苯基]-4-[[(3S)-3-(二甲基氨基)-1-吡咯烷基]甲基]-3-(三氟甲基)苯甲酰胺 | Bafetinib; 4-[[(3S)-3-Dimethylaminopyrrolidin-1-yl]methyl]-N-[4-methyl-3-[(4-pyrimidin-5-ylpyrimidin-2-yl)amino]phenyl]-3-(trifluoromethyl)benzamide; Benzamide, N-(3-((4,5'-bipyrimidin)-2-ylamino)-4-methylphenyl)-4-(((3S)-3-(dimethylamino)-1-pyrrolidinyl)methyl)-3-(trifluoromethyl)-; Inno 406; Inno-406; Ns 187; Unii-nvw4Z03I9b; Bafetinib (INNO-406); N-[3-([4,5'-BipyriMidin]-2-ylaMino)-4-Methylphenyl]-4-[[(3S)-3-(diMethylaMino)-1-pyrrolidinyl]Methyl]-3-(trifluoroMethyl)benzaMide | ![]() | C30H31F3N8O | 详情 | 供应商 |
| 1337532-51-0 | 5-溴-7-甲基-4-氨基吡咯[2,3-D]嘧啶; 5-溴-7-甲基-4-氨基吡咯[2,3-D]嘧啶 | 5-BroMo-7-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine | ![]() | C7H7BrN4 | 详情 | 供应商 |